InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Kristen Ambrose, SVP & Chief Accounting Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 14 open-market SEC Form 4 transactions: 0 purchases worth $0 and 14 sales worth $4.8M, reported from Apr 25, 22 to Feb 26, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 26, 26 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 357 | $483.36 | $173K |
| Feb 25, 26 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 223 | $486.35 | $108K |
| Feb 18, 26 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 638 | $473.68 | $302K |
| Feb 17, 26 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 1.6K | $489.46 | $762K |
| Feb 11, 26 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 1.4K | $460.43 | $634K |
| Feb 25, 25 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 884 | $480.95 | $425K |
| Feb 18, 25 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 671 | $455.06 | $305K |
| Feb 11, 25 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 1.4K | $459.83 | $633K |
| Apr 2, 24 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 240 | $419.00 | $101K |
| Feb 26, 24 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 883 | $425.70 | $376K |
| Feb 12, 24 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 1.4K | $420.24 | $577K |
| May 30, 23 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 289 | $329.82 | $95K |
| Feb 27, 23 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 982 | $289.63 | $282K |
| Apr 25, 22 | VRTXVERTEX PHARMACEUTICALS INC / MA | SELL | 104 | $271.68 | $28K |